One page, thousands of outlets. See who else covered it.
The combination regimen significantly extended the time patients lived without their melanoma returning, compared with Keytruda alone.
We haven't written up this one. CNBC has the full story — the link below goes straight to it.
One offers concentrated exposure to 29 pharma giants with lower volatility, while the other provides broader diversification across 251 biotech companies at a cheaper cost.
This single data point is also crucial to the company's long-term investment thesis.
While elevated prices could continue to influence jewellery purchases, investment demand is expected to remain supportive
Ripple said the $275 million raised will support its expansion into traditional financial services such as prime brokerage and multi-asset clearing, citing strong demand from institutions.
New York-headquartered Siguler Guff is a multi-strategy private markets investment firm which has approximately $18.4 billion of assets under management as of December 31, 2025
